RNAi Technology Market
RNAi Technology Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
RNAi Technology Market Size and Growth
The global RNAi technology market is projected to reach $2.69 billion by 2025, with a CAGR of 8.8% during the forecast period. Factors such as increasing demand for personalized medicine, advancements in technology, and rising investments in research and development are driving market growth. Key players include Alnylam Pharmaceuticals and Arrowhead Pharmaceuticals. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Alnylam Pharmaceuticals
◍ Dicerna Pharmaceuticals, Inc.
◍ Arrowhead Pharmaceuticals, Inc.
◍ Ionis Pharmaceuticals, Inc.
◍ Quark Pharmaceuticals, Inc.
◍ Arbutus Biopharma
◍ Benitec Biopharma
◍ Calando
◍ Silence Therapeutics
◍ Gotham Therapeutics
The RNAi technology market is competitive with companies like Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Arrowhead Pharmaceuticals, Ionis Pharmaceuticals, Quark Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, Calando, Silence Therapeutics, and Gotham Therapeutics. These companies develop therapies using RNAi technology, contributing to the growth of the market.
- Alnylam Pharmaceuticals: $566 million in 2020
- Dicerna Pharmaceuticals: $100 million in 2020
- Arrowhead Pharmaceuticals: $96 million in 2020
Request Sample Report
Market Segmentation
By Application
Drug Discovery & Development
Therapeutics
Drug Delivery
By Product
◍ Cancer
Liver Disorders
Respiratory Disorders
Others Request Sample Report
Neurological Disorders
Autoimmune Disorders
Others
◍
◍
◍
◍
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ 37.59 Billion
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients